Pulmonx (LUNG) Revenue (2019 - 2025)

Pulmonx (LUNG) has 7 years of Revenue data on file, last reported at $21.5 million in Q3 2025.

• Revenue for Q3 2025 came in at $21.5 million, up 5.47% year-over-year; the trailing twelve-month figure through Sep 2025 was $91.7 million (up 15.59% YoY), and the FY2024 annual result was $83.8 million, up 22.01% from the prior year.
• Revenue eased to $21.5 million in Q3 2025 per LUNG's latest filing, from $23.9 million in the prior quarter.
• Over five years, Revenue peaked at $23.9 million in Q2 2025 and troughed at $9.2 million in Q1 2021.
• A 5-year average of $17.0 million and a median of $17.2 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2021 and 2022: Revenue jumped 232.24% in 2021, then increased 1.82% in 2022.
• A 5-year view of Revenue shows it stood at $13.7 million in 2021, then gained by 12.53% to $15.4 million in 2022, then increased by 24.98% to $19.3 million in 2023, then grew by 23.28% to $23.8 million in 2024, then slipped by 9.52% to $21.5 million in 2025.
• Business Quant data shows LUNG's Revenue at $21.5 million in Q3 2025, $23.9 million in Q2 2025, and $22.5 million in Q1 2025.